isatin has been researched along with moxifloxacin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Z; Fan, Y; Gao, F; Lu, G; Ma, L | 1 |
| Gao, F; Huang, G; Kong, F; Xiao, J; Ye, L | 1 |
| Liu, H; Wang, X; Xu, Z; Yang, M; Zhang, Y | 1 |
| Chen, R; Guo, D; Liu, Y; Ma, T; Shi, X; Xu, Y; Xue, H; Zhang, J | 1 |
4 other study(ies) available for isatin and moxifloxacin
| Article | Year |
|---|---|
Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Isatin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Vero Cells | 2019 |
Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Humans; Isatin; Molecular Docking Simulation; Molecular Structure; Moxifloxacin; Structure-Activity Relationship; Triazoles | 2019 |
Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isatin; Molecular Structure; Moxifloxacin; Polymerization; Structure-Activity Relationship; Triazoles; Tubulin | 2020 |
Moxifloxacin Derivatives with Potential Antibacterial Activity against Methicillin- Resistant Staphylococcus Aureus (MRSA).
Topics: Anti-Bacterial Agents; DNA Topoisomerase IV; Fluoroquinolones; Isatin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Triazoles | 2021 |